Deep Dives into Peptide Science
Research breakdowns, protocol design, and the latest findings from the world of peptide science. Written for researchers who care about the evidence.
The Oral GLP-1 Revolution: How Foundayo Bests Injectable Semaglutide
Foundayo (orforglipron) outperforms injectable semaglutide in head-to-head Phase 3 trials, offering superior A1C reduction and weight loss as an oral small-molecule GLP-1 RA.
The GLP-1 Pill Wars Have Begun. Here's What Actually Changed.
Eli Lilly's Foundayo just became the first GLP-1 pill you can take without food restrictions. Novo Nordisk's oral semaglutide is heading to teenagers. The injection era is ending — but the details matter.
The FDA Is Reviewing 12 Peptides. Here's What That Actually Means.
After two years of restrictions, the FDA is provisionally removing 12 peptides from its banned list and scheduling formal reviews. Which ones are back, what the science says, and what patients should know right now.
The Peptide That Heals Everything: What 150 Studies Actually Reveal
BPC-157 was isolated from human gastric juice in the 1990s. Three decades later, 150+ papers suggest it might be the most versatile repair peptide ever studied — and almost nobody's heard of it.
The Drug Quietly Revolutionizing 6 Areas of Medicine (And It's Not About Weight)
Everyone knows Ozempic for weight loss. But semaglutide is being studied for Alzheimer's, heart disease, liver failure, addiction, and chronic inflammation — and the data is extraordinary.
How to Build a Peptide Stack That Actually Makes Scientific Sense
Forget the forum hype. Here's a systematic framework for designing peptide protocols — from objective definition to compound selection, synergy principles, and the mistakes that trip up 90% of beginners.
Why Smart Researchers Stack Peptides: The Science of Synergy
BPC-157 + TB-500. Ipamorelin + CJC-1295. Semax + Selank. The most effective peptide protocols aren't single compounds — they're carefully designed combinations. Here's the science behind why.